Head and Neck Cancer News
The daily head and neck cancer news is a unique cancer news service that evaluates all aspects of head and neck cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for head and neck cancer prevention, early detection and head and neck cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making head and neck cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Head and Neck Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Head and Neck Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
Media Contact: Lauren Abel MCS Healthcare Public Relations (800) 477-9626 laurena@mcspr.com National Video Contest Inspires Awareness of Oral, Head and Neck Cancer New survey shows few Americans recognize... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
The tricyclic antidepressant doxepin reduces oral mucositis in patients who receive radiation for head and neck cancer, according to the results of a study presented at the 54th annual meeting of the American... Continue Reading
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading
Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were... Continue Reading
The US Food and Drug Administration has expanded the approval of Erbitux® (cetuximab) to include the initial treatment, in combination with platinum-based chemotherapy, of selected patients with recurrent... Continue Reading
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service; Laurance S. Rockefeller Chair Integrative Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), click here for Dr.... Continue Reading
The Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that boys be vaccinated against human papillomavirus (HPV). Human papillomaviruses... Continue Reading
Latest Head and Neck Cancer News By Stage
General
National Video Contest Inspires Awareness of Oral, Head and Neck Cancer (February 21, 2013)
Media Contact: Lauren Abel MCS Healthcare Public Relations (800) 477-9626 laurena@mcspr.com National Video Contest Inspires Awareness of Oral, Head and Neck Cancer New survey shows few Americans recognize symptoms of a disease that struck more than 100,000... Continue Reading
Doxepin Reduces Mouth Pain from Radiation for Head and Neck Cancer (November 14, 2012)The tricyclic antidepressant doxepin reduces oral mucositis in patients who receive radiation for head and neck cancer, according to the results of a study presented at the 54th annual meeting of the American Society for Radiation Oncology in Boston,... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
Combined Treatment Provides Benefit for Nasopharyngeal Cancer (February 22, 2012)Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were published in the Journal of the National Cancer... Continue Reading
Erbitux Approved for New Use in Head and Neck Cancer (November 18, 2011)The US Food and Drug Administration has expanded the approval of Erbitux® (cetuximab) to include the initial treatment, in combination with platinum-based chemotherapy, of selected patients with recurrent or metastatic squamous cell head and neck cancer. Head... Continue Reading
More General
